Ohio State University Will Lead Review Of FDA’s Opioid Epidemic Response

FDA has tapped Ohio State University to evaluate the agency’s response to the opioid crisis, and recommend actions the agency can take based on existing and potentially new authorities, FDA chief Robert Califf announced earlier this week, coming three weeks after Califf unveiled the agency’s overdose prevention framework . The review team at Ohio State is familiar with opioid prescribing issues and has knowledge of the National Academies of Sciences Engineering and Medicine report from 2017 that provided recommendations for...